Okhla, Delhi
Business Type | Exporter, Supplier |
Treatment | Cancer |
Form | Tablets |
Dosage | As per Doctor's Prescription |
Click to view more |
Preferred Buyer From
Location | Worldwide |
Product Details
A drug used to treat adults with certain types of prostate cancer, pancreatic cancer, breast cancer, or ovarian, fallopian tube, or primary peritoneal cancer. It is also being studied in the treatment of other types of cancer. Olaparib blocks an enzyme involved in many cell functions, including the repair of DNA damage. Blocking this enzyme may help keep cancer cells from repairing their damaged DNA, causing them to die. Olaparib is a type of PARP inhibitor. Also called AZD2281, Lynparza, and PARP inhibitor AZD2281. US Brand Name(s): Lynparza. FDA Approved: Yes
Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers. Olaparib is indicated to treat breast cancer, ovarian cancer, fallopian tube cancer, peritoneal cancer, pancreatic cancer, and prostate cancer.
Olaparib is approved to treat:
Hi! Simply click below and type your query.
Our experts will reply you very soon.